The Improvement in the Clinical Management of Patients Undergoing Palliative Care After Training the Primary Care Team by a Specialized Team: A Systematic Review.

Med Sci (Basel)Oct 21, 2026 (epub)
Clinical ResearchFamily Medicine

Aila Davis Fanstone Pina Vieira, Deise Aparecida de A P Oliveira, Tamyris M F Sudré et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review assessed whether palliative care training for healthcare professionals in primary care improves symptom assessment and clinical management. Eight studies with varied designs were included. The review found that training generally improved professionals’ knowledge and confidence, but evidence was not robust that it sustainably improved patient clinical outcomes. The included evidence also described a predominantly generalist model: 95% of care was provided by generalists, while 53% of patients had no identifiable palliative care in the last year of life. The authors concluded that education alone is insufficient without broader system support.

Key findings

  • Across the included studies, training improved primary care professionals’ knowledge and confidence, but sustained improvement in patient clinical outcomes was not established.
  • Generalists provided 95% of palliative care, and 53% of patients had no identifiable palliative care in the last year of life.
  • Specialists were virtually absent in rural areas, where family doctors were responsible for nearly all palliative care.

Why it matters

The review highlights a gap between workforce education and the conditions needed to deliver effective palliative care. Training may strengthen clinicians’ knowledge and confidence, but limited clinical time, inadequate remuneration, weak specialist integration, and insufficient infrastructure can constrain its effect on patient care. These findings frame palliative care capacity as both an educational and health-system issue.

What to keep in mind

The eight included studies had varied designs, and the review found no robust evidence of sustained improvement in patient clinical outcomes.

Source

Published in Med Sci (Basel). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Family Medicine

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.